AU2001259158A1 - Treatment of skin damage using acetyl carnitine and phosphatidylcholine and/or ascorbyl fatty acid esters - Google Patents

Treatment of skin damage using acetyl carnitine and phosphatidylcholine and/or ascorbyl fatty acid esters

Info

Publication number
AU2001259158A1
AU2001259158A1 AU2001259158A AU5915801A AU2001259158A1 AU 2001259158 A1 AU2001259158 A1 AU 2001259158A1 AU 2001259158 A AU2001259158 A AU 2001259158A AU 5915801 A AU5915801 A AU 5915801A AU 2001259158 A1 AU2001259158 A1 AU 2001259158A1
Authority
AU
Australia
Prior art keywords
phosphatidylcholine
treatment
fatty acid
acid esters
skin damage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001259158A
Inventor
Nicholas V. Perricone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001259158A1 publication Critical patent/AU2001259158A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001259158A 2000-05-02 2001-04-25 Treatment of skin damage using acetyl carnitine and phosphatidylcholine and/or ascorbyl fatty acid esters Abandoned AU2001259158A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56310800A 2000-05-02 2000-05-02
US09563108 2000-05-02
PCT/US2001/013401 WO2001082878A1 (en) 2000-05-02 2001-04-25 Treatment of skin damage using acetyl carnitine and phosphatidylcholine and/or ascorbyl fatty acid esters

Publications (1)

Publication Number Publication Date
AU2001259158A1 true AU2001259158A1 (en) 2001-11-12

Family

ID=24249147

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001259158A Abandoned AU2001259158A1 (en) 2000-05-02 2001-04-25 Treatment of skin damage using acetyl carnitine and phosphatidylcholine and/or ascorbyl fatty acid esters

Country Status (2)

Country Link
AU (1) AU2001259158A1 (en)
WO (1) WO2001082878A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10129502A1 (en) * 2001-06-19 2003-01-09 Beiersdorf Ag Use of carnitine and / or one or more acyl-carnitines for the production of cosmetic or dermatological preparations to increase ceramide biosynthesis
DE10133200A1 (en) 2001-07-07 2003-01-23 Beiersdorf Ag Use of topical compositions containing carnitine and its precursors, derivatives or metabolites to, e.g. improve skin condition or to treat or prevent skin disorders, abnormal lipid peroxidation, reduced cell-cell communication or dandruff
ITRM20020055A1 (en) * 2002-02-04 2003-08-04 Aldo Fassi METALLIC SALTS OF CARNITINE, DIET / NUTRITIONAL SUPPLEMENTS THAT CONTAIN THEM AND DIET KITS TO COUNTER SEXUAL DISORDERS IN SUBJECTS
KR20040015533A (en) * 2002-08-13 2004-02-19 주식회사 웰스킨 Phosphatidylcholine composition for inducing fibrous tissue and method of inducing fibrous tissue
EP1610760A4 (en) * 2003-03-28 2008-01-09 Lonza Ag Topical l-carnitine compositions
US8937194B2 (en) * 2008-12-31 2015-01-20 Nitromega Corp. Topical compositions containing nitro fatty acids
SG178559A1 (en) 2009-08-25 2012-03-29 Medrx Co Ltd Transdermal composition of phosphatidylcholine and method for producing same
DE102012214038A1 (en) * 2012-08-08 2014-02-13 Beiersdorf Ag Use of active ingredient combinations of urea and carni-tin and / or one or more acyl-carnitines for the treatment and prophylaxis of atopic dermatitis and the diabetic foot
IT201700054488A1 (en) * 2017-05-19 2018-11-19 Giancarlo Muscas COMPOSITION FOR THE TREATMENT OF SKIN INFLAMMATORY FORMS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554647A (en) * 1989-10-12 1996-09-10 Perricone; Nicholas V. Method and compositions for treatment and/or prevention of skin damage and aging
US5376361A (en) * 1993-01-13 1994-12-27 Perricone; Nicholas V. Method and compositions for topical application to the skin for prevention and/or treatment of radiation-induced skin damage
US5667791A (en) * 1996-05-31 1997-09-16 Thione International, Inc. X-ray induced skin damage protective composition

Also Published As

Publication number Publication date
WO2001082878A1 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
AU2001259159A1 (en) Treatment of skin damage using conjugated linoleic acid and ascorbyl fatty acid esters
HUP0303881A3 (en) Pharmaceutical compositions containing fatty alcohols and fatty acid esters useful for treatment of inflammation
AU9164198A (en) Use of organic acid esters in dietary fat
AU6236900A (en) Method of preparing dimeric fatty acids and/or esters thereof
AU2000260550A1 (en) Treatment of skin damage using polyenylphosphatidylcholine
AU2003210321A1 (en) Use of sugar esters in cosmetic and/or pharmaceutical preparations
IS6205A (en) Pharmaceutical and nutritional formulations containing essential fatty acids and homocysteine-lowering agents
SG65631A1 (en) Preparation of acrylic acid and esters
AU5377400A (en) Concentration and purification of polyunsaturated fatty acid esters by distillation-enzymatic transesterification coupling
AU2003217759A1 (en) Omega-3 fatty acids or omega-3 phosphatidylcholine in the treatment of depression
AU2001286562A1 (en) Use of agaricus blazei murill to prevent or treat skin and other disorders
AU2003223930A1 (en) Pharmaceutical use of boronic acids and esters thereof
AU2001259158A1 (en) Treatment of skin damage using acetyl carnitine and phosphatidylcholine and/or ascorbyl fatty acid esters
AU3702997A (en) Manufacture of fatty acid esters of sorbitan as surfactants
ZA200502613B (en) Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents
AU7358800A (en) Compositions and methods for modification of skin lipid content
AU2058701A (en) Esters of vitamin D3 and uses thereof
AU7222598A (en) Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants
AU2003271049A1 (en) Use of amide or ester of sugar and of fatty acid, for treating and/or preventing dry skin
HK1044536A1 (en) Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
AU2634101A (en) Therapeutic preparations of highly unsaturated fatty acids
AU4666800A (en) Fatty acid esters of aromatic alcohols and their use in cosmetic formulations
AU2001250933A1 (en) Chitosan formulation with azelaic acid and other actives for the treatment of acne
AU4130597A (en) Use of essential fatty acids for the treatment and prevention of radiation damage to erythrocytes
AUPQ480399A0 (en) Unsaturated fatty acids and their uses in therapy